- Recent Supreme Court and Federal Circuit decisions and subsequent District Court applications of those decisions.
- U.S. Patent and Trademark Office rule changes.
- Strategic business use of patent portfolios in view of KSR and USPTO rule changes and other recent events.
- An international update on PCT trends and practices.
- A judges panel discussion of recent appellate decisions and the impact on pending litigation; resolution of discovery disputes and other motion practice issues; and the use of ADR.
- A corporate counsel panel discussion on patent business and legal concerns.
- Prosecution:
- The impact of new USPTO rules initiatives;
- USPTO biotech/pharma trends; and
- A discussion of EFS-Web and USPTO Web forms.
- Litigation:
- The impact of recent appellate decisions;
- Litigation in the Eastern District of Texas;
- Practical guidelines for e-discovery management; and
- Industry spotlights on pharma/biotech, electronics/semiconductor, and software patent litigation.
- Transactions:
- Drafting opinions of counsel in the wake of KSR and In re Seagate;
- Critical business considerations of a license agreement;
- The impact of MedImmune on licensing;
- Eighteen hidden dangers in your patent license agreement; and
- Patent valuation for litigation and licensing and patent auctions.
A program schedule and list of speakers for the New York Patent Law Institute can be found here, and a program schedule and list of speakers for the San Franscisco Patent Law Institute can be found here.
The registration fee for the conference is $1,495 (group discounts are available for groups of 4-14 members of the same organization). Those interested in registering for the conference can do so at the PLI website.
Comments